by Barry101 | Feb 2, 2017 | Press Release
PHILADELPHIA, Feb. 02, 2017 — Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”), announced today that it has entered into definitive agreements with several institutional investors for an offering of shares of...
by Barry101 | Feb 1, 2017 | Press Release
The attached letter can also be found on the company's website at http://ir.hemispherx.net/Events_Presentations
